NuCel recalls eye/ear products
This article was originally published in The Tan Sheet
Idaho Falls, Idaho-based NuCel Labs announced Jan. 29 a nationwide voluntary recall of its eye drops and eye/ear wash products. The recall follows an FDA inspection confirming the existence of bacteria and "particulate matter" in the products, making them non-sterile and posing risk of infection. All of the products labeled "Eye Drops Caution: Do Not Use With Implants" or "Eye/Ear Wash" are subject to recall, according to the firm. The company estimated 500 bottles of the products have been distributed nationwide and advised consumers who are in possession not to use the products but return them for refunds...
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.